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Abstract 
 
Carbohydrate molecules are involved in many of the cellular processes that are important 
for life. By combining the specific analyte targeting of carbohydrates with the multivalent 
structure and change of solution colour as a consequence of plasmonic interactions with 
the aggregation of metal nanoparticles, glyconanoparticles have been used extensively for 
the development of bioanalytical assays. The noble metals used to create the nanocore, 
the methodologies used to assemble the carbohydrates on the nanoparticle surface, the 
carbohydrate chosen for each specific target, the length of the tether that separates the 
carbohydrate from the nanocore and the density of carbohydrates on the surface all impact 
on the structural formation of metal based glyconanoparticles. This tutorial review 
highlights these key components, which directly impact on the selectivity and sensitivity of 
the developed bioassay, for the colorimetric detection of lectins, toxins and viruses.  
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Introduction 
The surface of mammalian cells is covered with a dense coating of carbohydrates known as the 
glycocalyx.1, 2 These cell surface carbohydrates are involved in numerous biological processes 
that are important for life, including: protein-carbohydrate interactions, associated with blood 
coagulation, the immune and pre-immune system, and the circulation and activity of pituitary 
hormones;3 carbohydrate-carbohydrate interactions, involved in embryogenesis, metastasis, 
fertilisation, and myelin compaction;4 and cell surface receptors that are ‘hijacked’ by protein 
toxins (e.g. cholera, tetanus and shiga toxins), by bacteria (e.g. Escherichia coli and 
Campylobacter jejuni) and viruses (e.g. influenza, herpes and papilloma) as a means of 
initiating infection.5-9 
 
With consideration of the importance of the biological processes that involve carbohydrate 
interactions, a wide variety of techniques have been developed to study ‘glycomics’.10, 11 For 
example, carbohydrate microarrays,12, 13 carbohydrate-modified polymers14-16 and 
carbohydrate-functionalised microparticles17 have all been developed to study carbohydrate 
recognition. Recently, the use of nanostructures functionalised with carbohydrates to study 
the processes and interactions in which carbohydrates are involved has grown substantially. 
Important characteristics of these ‘glyconanoparticles’ are the ease of functionalisation of the 
nanoparticle structure and their ability to mimic biological surfaces.18-20 Glyconanoparticles can 
be specifically tailored to allow for the bioanalytical detection of various biological targets.21-23 
Detection of such targets can be achieved by varying several properties of the carbohydrate-
functionalised nanoparticles viz.: 1) the material used to create the nanocore and the 
methodology applied to assemble the carbohydrate on the nanoparticle surface; 2) the 
carbohydrate ligand itself; 3) the length of the anchor chain tethering the carbohydrate to the 
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nanoparticle surface; and 4) the density of carbohydrate molecules on the nanoparticle 
surface. Fig. 1 highlights all of these parameters with the structure of a gold, or silver, 
glyconanoparticle where the ligands are self-assembled to the metal surface via a thiol moiety. 
 
 
Fig. 1. The structure of carbohydrate-functionalised nanoparticles showing the four variables 
used for the construction of a glyconanoparticle: 1) the nanoparticle core (red); 2) the 
carbohydrate chosen for each specific target (orange); 3) the anchor chain length that 
separates the carbohydrate from the nanoparticle core (blue); and 4) additional molecules, 
such as polyethylene glycol (PEG), used to dilute the density of carbohydrates on the 
nanoparticle surface (green).  
 
When the dimensions of metal particles are reduced to the nanoscale, the optical 
characteristics exhibited by a solution of the nanoparticles change from those of the bulk 
metal. The optical properties of metal nanoparticles are dominated by collective 
oscillations of conduction electrons in resonance with the incident electromagnetic 
radiation.24 This phenomenon is known as surface plasmon resonance, which is determined 
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by the metal, the size and shape of the nanoparticles, by the distance between the 
particles, and by the dielectric properties of the surrounding medium.25-27 Gold 
nanoparticles of ca. 16 nm diameter in aqueous suspension exhibit an intense surface 
plasmon absorption band centred at 520 nm and consequently the solution appears red in 
colour. This optical property is distance-dependent and upon aggregation, coupling 
interactions between the surface plasmon fields of the nanoparticles occur resulting in a 
broadening and a red-shift of the surface plasmon absorption band. Consequently, upon 
aggregation, when the interparticle distance decreases to less than 2.5 times the particles’ 
diameter,28 the colour of a suspension of gold nanoparticles changes from red to purple. 
This colour change is visible to the naked eye. The colour changes associated with 
nanoparticle aggregation were originally exploited by Mirkin et al., who showed that 13 nm 
diameter gold nanoparticles stabilised with single stranded DNA could be used to 
colorimetrically detect the complementary oligonucleotide.29 Recently, the first double 
stranded DNA-functionalised gold nanoparticles have been reported to investigate duplex 
to duplex interaction via a colorimetric bioassay.30 Gold nanoparticle-based colorimetric 
assays have also been reported for the detection of a variety of other species, including 
metal ions, anions, small organic molecules and proteins.31, 32 
 
Combining the specific analyte targeting of carbohydrates with the change of solution 
colour as a consequence of the aggregation of metal nanoparticles, glyconanoparticles 
have been extensively used for the development of colorimetric bioassays. This tutorial 
review will highlight how metal-based glyconanoparticles are constructed and then used 
for the development of colorimetric bioassays for the detection of lectins, toxins and 
viruses. 
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Noble metals used to synthesise the nanoparticle core 
One of the key variables that can be tailored in the synthesis of glyconanoparticles is the 
material used to form the nanoparticle core. Although different types of nanomaterials 
including CdS/ZnS quantum dots,33-38 upconverting nanoparticles,39 magnetic nanoparticles,40-
45 and carbon nanotubes,46 have been used for the synthesis of glyconanoparticles, the 
intrinsic colour changes associated with the aggregation of noble metal nanoparticles have 
ensured that these nanoparticles are extensively used for the development of bioassays. 
Among the noble metals, silver and especially gold are the most commonly used and this 
review will focus on the use of these metals for the synthesis of glyconanoparticles and their 
use in the development of colorimetric bioassays.  
 
Gold nanoparticles have been functionalised with a thiolated mannose derivative to develop a 
selective, quantitative and rapid colorimetric detection method for Concanavalin A (ConA).47 
ConA, a lectin from Canavalia ensiformis, is a carbohydrate binding protein that has been 
extensively used in the study of protein-carbohydrate interactions using glyconanoparticles. 
This ‘model’ protein is well known to bind selectively to α-mannosides48 and α-glucosides. The 
binding of ConA to N-acetylglucosamine has also been reported.49 The glyconanoparticles were 
synthesised using a two-step procedure that involved citrate-reduced gold nanoparticles and a 
thiolated carbohydrate ligand.47 In the first step, gold nanoparticles were prepared via the 
citrate reduction of hydrogen tetrachloroaurate (HAuCl4) following the well-established 
method reported by Turkevich et al..50, 51 This method produces citrate-stabilised gold 
nanoparticles of an average size of ca. 16 nm diameter at a concentration of ca. 3 nM. In the 
second step, the citrate-stabilised gold particles were reacted with a previously synthesised 
thiolated mannopyranoside ligand. During this reaction, the citrate on the surface of the gold 
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particles was replaced by the thiolated ligand, yielding the mannose functionalised 
glyconanoparticles. The unbound ligand was removed by centrifugation, using centrifugal filter 
units of the appropriate molecular weight cut-off. The glyconanoparticles were then 
resuspended in Tris buffer, or in another appropriate buffer, yielding a red suspension. The size 
of the nanoparticles can be measured by transmission electron microscopy (TEM) or by 
dynamic light scattering (DLS). The concentration of a dispersion of citrate capped gold 
nanoparticles can be calculated with the Beer-Lambert law using an extinction coefficient at 
520 nm of 2.4x108 M-1 cm-1.52 Citrate-capped gold nanoparticles exhibit a surface plasmon 
absorption band centred at ca. 520 nm (Fig. 2). Upon displacement of the citrate and self-
assembly of the thiolated mannopyranoside, the surface plasmon absorption band shows a 
small red-shift with the maximum centred at ca. 523 nm (Fig. 2a). The shift in the maximum of 
the UV-vis extinction spectrum indicates a change in the dielectric nature of the metal surface 
and confirms the functionalisation of the nanoparticles. The purified mannose-functionalised 
gold nanoparticles reported by Hone et al.47 were resuspended in Tris buffer at pH 7.6. At pH > 
7, ConA has four sites that bind to α-D-mannose residues.53 Thus, each ConA molecule could, in 
principle, bind up to four mannose-functionalised gold nanoparticles via the specific lectin-
carbohydrate interaction, although due to geometric constrains each lectin is likely to bind to 
two, or possibly three, mannose ligands. Furthermore, each nanoparticle is functionalised with 
numerous mannose ligands thereby enabling binding of each glyconanoparticle to several 
ConA molecules. Upon addition of increasing concentrations of ConA to a solution of mannose-
functionalised gold nanoparticles, a shift to longer wavelengths in the surface plasmon 
absorption band was observed concomitant with a broadening of the spectrum and an 
increase in the UV-vis extinction at 620 nm (Fig. 2a). These changes confirmed the aggregation 
of the glyconanoparticles in a lectin concentration-dependent manner. The aggregation could 
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be observed by the naked eye due to the colour change of the nanoparticle suspension, from 
deep red to purple (Fig. 2b). Further to the measurement of the UV-vis extinction spectrum, 
TEM can be employed to visualise the aggregation of the glyconanoparticles in the presence of 
ConA (Fig. 2b). The designed glyconanoparticles enabled the colorimetric detection of sub-μM 
(0.192 – 0.385 μM) concentrations of ConA within 30 sec. To establish the specificity of the 
interaction between mannose-functionalised nanoparticle and the ConA, control experiments 
using Tetragonolobus purpureus lectin, with affinity for L-fucose, were performed with no 
changes in the UV-vis extinction spectrum of the nanoparticles observed.47 
 
Fig. 2. a) UV-vis extinction spectra of: red) citrate reduced gold nanoparticles and black) 
mannose-functionalised gold nanoparticles 40 min following addition of increasing 
concentrations of ConA (from 0 to 0.32 µM). b) Transmission electron micrographs and 
vials containing samples of mannose-functionalised gold nanoparticles left) before and 
right) 30 min after addition of 0.32 µM Con A. The overall concentration of nanoparticles in 
the sample remains constant. Scale bars are 100 nm.47 Figure adapted with permission 
from Ref. 47. Copyright (2003) American Chemical Society. 
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Following a similar approach, a simple and rapid bioassay for the detection of cholera toxin 
using lactose-functionalised gold nanoparticles has been developed.54 Cholera toxin is 
produced by Vibrio cholerae, the causative agent of cholera, an acute intestinal disease that is 
prevalent in developing countries. Cholera toxin is known to bind to the pentasaccharide head 
group of the GM1 ganglioside in the intestine. The interaction between cholera toxin and the 
ganglioside can be mimicked using lactose, a disaccharide that terminates with a galactose 
unit, a component of the GM1 pentasaccharide head group. A lactose derivative containing a 
thiolated anchor was synthesised and self-assembled onto 16 nm gold nanoparticles. Addition 
of cholera toxin B subunit (CTB) to the lactose-functionalised gold nanoparticles resulted in 
aggregation of the particles, accompanied by a red to deep purple colour change due to the 
changes of the surface plasmon absorption band (Fig. 3). The bioassay was able to detect and 
quantify the CTB within 10 min. The selectivity of the lactose-stabilised gold nanoparticles 
towards CTB was investigated by testing the bioassay in the presence of potentially interfering 
ions and a protein. The sensing system was freeze-dried, reconstituted and then tested with a 
model clinical sample consisting of electrolytes found in the watery stool that is typical of 
cholera patients. In the electrolyte medium, the lowest detectable concentration of CTB was 
found to be 110 nM while the theoretical detection limit for CTB was determined to be 54 nM. 
The developed bioassay proved to be simple, fast and robust. The method enabled the 
quantitative detection of CTB and, since it works after freeze-drying, can be easily transported 
to environments where cholera outbreaks are likely to occur.54  
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Fig. 3. a) Schematic representation of the aggregation of lactose-functionalised gold 
nanoparticles in the presence of cholera toxin showing the relative scale of the toxin with 
respect to the nanoparticles; and b) UV-visible extinction spectra of lactose-functionalised gold 
nanoparticles upon addition of CTB at varying concentrations (from 0.22 to 2.20 µM): 0 µM 
CTB (black solid line) and 2.20 µM CTB (red solid line).54 Figure adapted with permission from 
Ref. 54. Copyright (2007) American Chemical Society. 
 
The optical properties of silver at the nanoscale are also distance-dependent. Silver- and gold-
based glyconanoparticles have been compared to establish whether either metal exhibits 
optimal characteristics for bioassay development.55 Mannose-functionalised silver 
nanoparticles were synthesised in two steps: a silver salt was reduced using sodium 
borohydride yielding a vivid yellow coloured suspension of silver nanoparticles, which were 
then mixed with a thiolated mannose derivative ligand for 48 h to self-assemble the ligand on 
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the surface of the nanoparticles. The excess mannose ligand was removed by dialysis and the 
final suspension of mannose-functionalised silver nanoparticles was kept in Tris buffer (10 mM, 
pH 7.6). These mannose-functionalised silver nanoparticles of ca. 16 nm diameter were a vivid 
yellow colour, as shown in Fig. 4a. Red suspensions of mannose- or lactose-functionalised gold 
nanoparticles were synthesised as described for the gold nanoparticles stabilised with the 
thiolated lactose-derivative ligand54 (Fig. 4b for lactose-functionalised gold nanoparticles). The 
synthesised silver nanoparticles exhibited an intense surface plasmon absorption band at 395 
nm that shifted to 401 nm upon addition of the thiolated mannose ligand. Similarly, the 
characteristic surface plasmon absorption band of the gold nanoparticles red-shifted from 520 
to 523 nm upon functionalisation. Aggregation of either silver or gold nanoparticles 
functionalised with the mannose ligand was observed upon addition of Con A resulting in a 
shift in the surface plasmon absorption band and a consequent colour change of the solution. 
When comparing the mannose-functionalised silver nanoparticles with the mannose-
functionalised gold nanoparticles, the former provided an assay for Con A with the largest 
linear range (between 0.08 and 0.26 µM), and a greater kinetic rate of aggregation. However, 
in terms of sensitivity, the mannose-functionalised gold-nanoparticle-based assay was 
optimum. To examine the specificity of the bioassay, the prepared lactose-functionalised gold 
nanoparticles were mixed with a solution of mannose-functionalised silver nanoparticles (Fig. 
4c) to give an aggregation assay capable of detecting two different lectins, Con A or the 
galactose specific Ricinus communis agglutinin 120 (RCA120). When either lectin was added to 
the mixed glyconanoparticles, selective recognition of the respective natural ligand was shown 
by aggregation of a single metal nanoparticle. Centrifugation and removal of the aggregated 
species enabled further bioassay measurements using the second glyconanoparticle system.55 
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Fig. 4. a) Mannose-functionalised silver nanoparticles (3 nM, ca. 16 nm in diameter); b) 
lactose-functionalised gold nanoparticles (3 nM, ca. 16 nm in diameter); and c) a 50:50 mixture 
of mannose-silver and lactose-gold nanoparticles.55 Figure reproduced with permission from 
Ref. 55. Copyright (2006) American Chemical Society. 
 
 
While the comparative study showed that silver glyconanoparticles could be readily used for 
colorimetric bioassays, and indeed some other examples of silver glyconanoparticles can be 
found in the literature,56-58 the vast majority of the reported colorimetric bioassays have been 
developed using gold nanoparticles. The preference towards gold is likely due to the high 
stability and the biocompatibility of such gold nanomaterials. Consequently, the remainder of 
this tutorial review will focus on colorimetric bioassays developed using gold nanoparticles. 
 
The importance of the nanoparticle size for the development of colorimetric assays has been 
studied using a model system for the detection of Ni(II) ions.59 Although the results suggest 
that the use of 45 nm nanoparticles provides the optimal performance of the system, the 
majority of the reported glyconanoparticle-based assays use 8 – 20 nm diameter nanoparticles. 
The influence of the particle size for the development of colorimetric bioassays has been also 
studied by Niikura et al..60 Gold nanoparticles of 5, 10 and 15 nm diameter were functionalised 
with a thiolated sialic acid derivative for the colorimetic detection of John Cunningham (JC) 
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virus. The authors were able to optically detect the virus only when using the 15 nm sized 
glyconanoparticles in the presence of dextran within the solution.60 
 
 
Assembly of the nanoparticles 
The synthesis of glyconanoparticles for colorimetric bioassays can be achieved following 
two different strategies. The first strategy is to synthesise a carbohydrate ligand which is 
then self-assembled onto previously-synthesised gold nanoparticles. This strategy was used 
for the synthesis of the mannose and lactose gold nanoparticles described above. One of 
the major advantages of this strategy is that the synthesised carbohydrate ligand can be 
fully characterised prior to assembly onto the gold nanoparticle surface. The second 
strategy uses pre-synthesised gold nanoparticles that are functionalised with a non-glyco-
ligand. The particles are then reacted with a carbohydrate to yield the glyconanoparticle of 
interest. Examples of both strategies utilised for the synthesis of glyconanoparticles are 
given below.  
 
The first strategy typically involves the self-assembly of thiol-derivatised carbohydrates. 
However, the self-assembly of carbohydrates to the gold surface using thioctic acid and its 
influence on protein binding has been also investigated.61 Thioctic acid derivatives possess two 
sulfur atoms thereby providing two points of attachment to the surface of the gold particles. 
Four ligands were individually synthesised, α-D-mannopyranoside and α-1,3-D-
mannopyranosyl(α-1,6-D-mannopyranosyl)-α-D-mannopyranoside-based thiols (1a and 2a, see 
Fig. 5) and the corresponding thioctic amides (1b and 2b, see Fig. 5). The synthesised ligands 
were attached to the surface of gold nanoparticles (ca. 17 nm). It was observed that the 
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thioctic-amide systems (Fig. 5, 1b and 2b) gave a greater response toward ConA than that of 
the mannoside- and trimannoside-thiols (Fig. 5, 1a and 2a, respectively). Further, it was 
observed that the thioctic-amides did not show non-specific aggregation when they were in 
contact with other proteins such as Tetragonolubus purpureas lectin, RCA120, fibrinogen and 
cytochrome c.61  
 
Fig. 5. Structure of the α-D-mannopyranoside and α-1,3-D-mannopyranosyl(α-1,6-D-
mannopyranosyl)-α-D-mannopyranoside-based thiols (1a and 2a) and the corresponding 
thioctic-amides (1b and 2b).61 Figure reproduced from Ref. 61. 
 
 
Ricinus communis (ricin: RCA60) is a toxic lectin that is considered to be a bioterrorism threat.62 
The mechanism of toxicity of ricin involves the binding of its two carbohydrate-binding sites to 
the β-D-galactopyranose (β-Gal) or β-D-N-acetylgalactosamine (β-GalNAc) residues on the 
surface of the host cell. Based on this mode of action, Uzawa et al. developed a facile and 
sensitive colorimetric bioassay for RCA60 using gold nanoparticles functionalised with a 
thiolated β-lactosyl ceramide ligand.63 Upon addition of either the RCA60 toxin or the surrogate 
agglutinin RCA120 to a solution of the glyconanoparticles, a change of colour from red to purple 
was observed by the naked eye. This colour change was not observed in the presence of other 
plant lectins, including those from jack bean, soybean, peanut, Osage orange trees, Amur 
maackia trees and clary sage. Additionally, no colour change was observed in the presence of 
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non-carbohydrate binding proteins, such as bovine serum albumin and γ-globulin. The 
aggregation of the glyconanoparticles in the presence of RCA60 could be reversed by addition 
of an excess of lactose. RCA60 could be distinguished from RCA120 using β-D-galactosyl ceramide 
functionalised gold nanoparticles, since RCA60 does not react with these glyconanoparticles 
while RCA120 induces their aggregation. The developed bioassay could detect RCA60 in 
concentrations of less than 3.3 μg/mL in 10 min or 1.7 μg/mL in 30 min.63 
 
In the examples described above the carbohydrate ligands are attached to the gold 
nanoparticles via a thiol or thioctic acid moiety. Carbohydrate ligands have also been attached 
to gold particle surfaces via atoms other than sulfur. For example, monosaccharide modified 
peptides containing an amino group have been bound to the gold surface yielding 
glyconanoparticles as optical probes for lectin detection.64 While Ding et al. have based the 
stabilisation of their mannan-functionalised gold nanoparticles on the interaction between the 
gold surface and the hydroxyl groups on the carbohydrate.65 
 
The second strategy for the assembly of glyconanoparticles avoids the synthesis of the 
required thiolated carbohydrate ligands. For example, Wang et al. functionalised citrate 
stabilised gold nanoparticles (ca. 20 nm) with perfluorophenylazide disulfide, the nitrene 
species of which were photochemically activated to couple the carbohydrates of interest.66, 67 
This method was used to synthesise monosaccharide- and disaccharide-functionalised gold 
nanoparticles. Aggregation studies in the presence of ConA were performed to investigate 
whether the recognition ability of the carbohydrates changes upon coupling.66  
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The coupling of carbohydrates using microwave radiation is another alternative for the 
functionalisation of gold nanoparticles.68 In this example, gold nanoparticles were first 
functionalised with di(N-succinimidyl)3,3’-dithiodipropionate and then reacted with 2-
mercaptoethylamine hydrochloride via succinimidyl-amino covalent binding. This reaction step 
left free sulfhydryl groups on the surface of the nanoparticles that reacted with the maleimide 
on N-(β-maleimidopropionic acid) hydrazine. In a final step, the carbohydrate of interest was 
conjugated to the hydrazine-functionalised nanoparticles using microwave heating (15 min, 
600 W). During the microwave heating a hydrazone is formed between the amine group of the 
hydrazine and the carbonyl group at the reducing end of the carbohydrate of interest. This 
synthetic procedure yielded glyconanoparticles with a low extinction intensity as compared to 
the initial citrate stabilised gold nanoparticles (an intensity decrease from ca. 1.1 to 0.25). 
Maltose-, mannose-, glucose-, lactose- and D-mannopentaose-functionalised gold 
nanoparticles were synthesised using this method and their interaction with ConA was 
investigated.68 
 
1-Deoxy-1-thio-β-D-glucose sodium salt was used as the reducing and stabilising agent in the 
synthesis of gold nanoparticles of different sizes.69 The thioglucoses functionalising the gold 
surface were found to be partially oxidised, forming carboxyl groups that were then activated 
via N-hydroxysuccinimide (NHS)/N-3-(dimethylaminopropyl)-N’-ethylcarbodiimide (EDC) to 
covalently couple p-aminophenyl α-D-mannoside. The synthesised glyconanoparticles were 
able to colorimetrically detect ConA rather than peanut agglutinin which binds specifically to 
the carbohydrate sequence galactose-β-1,3-N-acetylgalactosamine (Gal-β-1,3-GalNAc).69  
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Otsuka et al. reported the synthesis of glyconanoparticles for the sensing of RCA120 using a 
two-step protocol.70 First, HAuCl4 was reduced with sodium borohydride in the presence of an 
acetal-PEG-SH ligand (PEG:Au molar ratio = 1/6:1). Subsequently, the acetal group was 
converted into an aldehyde group which was then reacted with p-aminophenyl-β-D-
lactopyranoside and/or p-aminophenyl-α-D-mannopyranoside yielding the corresponding 
glyconanoparticles (ca. 8.9 nm).70 The presence of RCA120 induced the aggregation of the 
glyconanoparticles and thus, a colour change of the dispersion. The aggregation of the 
nanoparticles in the presence of RCA120 was reversible upon addition of D-galactose. The 
influence of the dilution of the lactose coverage on the nanoparticle surface for the lectin 
detection was also reported.70 The optimisation of the density of the carbohydrate ligand on 
the glyconanoparticle surface is an important parameter and will be considered in more detail 
below.  
 
 
The carbohydrates for each specific target 
When designing a glyconanoparticle system for a colorimetric bioassay, the carbohydrate 
itself is obviously of central importance. Most naturally occurring protein-carbohydrate and 
carbohydate-carbohydate interactions are relatively weak.71 The way Nature overcomes 
these weak interactions is through multivalent binding, where several carbohydrates are 
involved in the interaction.72 Glyconanoparticles mimic this multivalent binding since a 
large number of the carbohydrate ligands are present on each particle. 
 
In a recent study, Marín et al. have demonstrated that a thiolated trivalent sialic acid 
derivative (Fig. 6a) is far superior than the monovalent sialic acid derivative (Fig. 6b
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colorimetric detection of a human influenza virus.73 Haemagglutinin (HA) is one of two 
major glycoproteins found on the surface of influenza viruses. HA recognises and binds to 
the sialic acid present on the surface of a host cell, thereby enabling infection of the cell.74 
Since viral HA is trivalent in nature,75 it was considered that the trivalent sialic acid 
derivative would better mimic the surface of a host cell. The binding affinity of the 
synthesised trivalent sialic acid functionalised nanoparticles toward the human influenza 
virus X31 (H3N2) was compared to that of gold nanoparticles functionalised with a 
monovalent sialic acid derivative. The changes in the surface plasmon absorption band of 
both types of glyconanoparticles were monitored upon addition of increasing 
concentrations of the human influenza virus X31. For the gold nanoparticles functionalised 
with the trivalent ligand, a red-shift in the surface plasmon absorption band with the 
associated colour change from an initial deep red to a lighter red was observed 30 min 
after addition of the virus. These changes in the properties of the glyconanoparticles 
indicate the aggregation of the nanoparticles around the virus particle (Fig. 6c). As shown 
in Fig. 6d, the intensity of the surface plasmon absorption band at 525 nm of the trivalent 
ligand functionalised gold nanoparticles decreased from ca. 0.75 to 0.17 when a 
concentration of 3 µg/mL of human influenza virus X31 was added to the sample. However, 
the extinction intensity at 525 nm for the nanoparticles functionalised with the monovalent 
ligand, under the same conditions, only decreased from ca. 0.75 to 0.56. These results 
highlight that the trivalent sialic acid ligand binds to the human influenza virus with greater 
affinity than the monovalent ligand. It is clear that knowledge regarding the specific 
interactions between the protein and carbohydrate is essential for the optimal design of 
the glyconanoparticles for sensitive colorimetric bioassays. 
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Fig. 6. a) Chemical structure of the thiolated trivalent sialic acid derivative ligand; b) 
chemical structure of the thiolated monovalent sialic acid derivative ligand; c) schematic 
representation of the aggregation of trivalent sialic acid functionalised gold nanoparticles 
in the presence of influenza virus; the ligand on the surface of the gold nanoparticles binds 
to the haemagglutinin on the surface of the virus inducing aggregation; and d) changes in 
the extinction intensity at 525 nm of gold nanoparticles functionalised with a trivalent sialic 
acid derivative ligand (black), a monovalent sialic acid derivative ligand (red) and a 
polyethylene glycol derivative ligand (blue) in the presence of increasing concentrations of 
human influenza virus X31 (H3N2) (from 0 to 3.0 µg/mL).73 Figure adapted from Ref. 73. 
 
 
Length of the anchor chain that tethers the carbohydrate to the nanoparticle 
core 
The chain length of the anchor that attaches the carbohydrate to the nanoparticle surface 
has an influence on the stability and the sensitivity of the glyconanoparticles. Ligands with 
a longer alkyl anchor chain give a more stable monolayer whereas a shorter chain length 
gives better sensitivity for the aggregation assays. 
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As previously discussed, the relationship between the interparticle distance and the changes in 
the optical properties of DNA-modified gold nanoparticles were initially studied by Mirkin and 
co-workers.52 The authors showed that the changes in the optical properties were dependent 
on the interparticle distance and on the number of particles that form the aggregate, both 
properties dependent upon the spacer length of the oligonucleotide. In the field of 
colorimetric bioassays using glyconanoparticles, the aggregation of a variety of lactose-
functionalised nanoparticles in the presence of calcium ions was shown to be dependent on 
the anchor chain length of the carbohydrate ligand.76 Calcium is a divalent cation in solution 
that is known to be essential for carbohydrate-carbohydrate binding.77 Calcium is able to 
chelate to lactose, a disaccharide consisting of D-glucose and D-galactose, via the oxygen 
atoms of the HO(2)-HO(3) pair of hydroxyl groups of the glucose in one lactose moiety and 
those of the HO(3)-HO(4) of the galactose unit of a second lactose unit. Based on these calcium 
ion-mediated carbohydrate-carbohydrate interactions, gold nanoparticles (ca. 16 nm) were 
individually functionalised with four different lactose derivatives of varying length of anchor 
chain (Fig. 7a). Addition of calcium ions to these glyconanoparticles induced aggregation. The 
sensitivity and linear dynamic range of the lactose-stabilised gold nanoparticles were found to 
be dependent on the length of the anchor chain (Fig. 7b). The shorter the anchor chain, the 
more sensitive the assay, with the shortest chain giving the lowest limit of detection at 0.8 mM 
calcium.76  
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Fig. 7. a) Structure of the lactose derivative ligands used for the functionalisation of the gold 
nanoparticles; and b) effect of ethylene oxide anchor chain length (m = 0, 1, 2 and 3) on the 
sensitivity of calcium-mediated particle aggregation.76 Figure adapted with permission from 
Ref. 76. Copyright (2006) American Chemical Society. 
 
The effect of the anchor chain length for the design of optimally presented glyconanoparticles 
for the colorimetric detection of RCA120 and ConA has also been examined.78 Gold 
nanoparticles (ca. 16 nm) were functionalised with either a long- (ca. 15 Å) or a short- (ca. 6.2 
Å) chain galactose thiolated ligand (Fig. 8). Addition of RCA120 induced the aggregation of the 
glyconanoparticles which was observed by a visual colour change and a red-shift in the surface 
plasmon absorption band. The nanoparticles functionalised with the short-anchor chain ligand 
provided superior aggregation upon addition of RCA120, displaying a lower detection limit, a 
greater change in extinction intensity and a larger linear dynamic range. However, the longer-
anchor chain ligand provided a more stable sensing system.  
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Fig. 8. Chemical structure of the a) long- and b) short-anchor chain galactose thiolated 
derivative ligand.78 Figure reproduced from Ref. 78. 
 
Shiga-like toxins belong to the same family of AB5 toxins as the cholera toxin.79, 80 Shiga-like 
toxin is produced by the Escherichia coli bacterium. The B-subunit of the toxin produced by E. 
coli strain O157:H7 specifically recognises the globotriose (Pk) blood group antigen, which 
contains the trisaccharide αGal(1→4)βGal(1→4)βGlc. Each of the five B-subunits has three 
binding sites for Pk. Chien et al. have prepared two derivatives of Pk with different chain lengths 
and self-assembled these onto gold nanoparticles of differing sizes (4, 13 and 20 nm).81 These 
glyconanoparticles were used to assess the binding affinity towards the shiga-like toxin with 
the view to develop a surface plasmon resonance competition assay. The results obtained 
show that a longer chain length enhances the binding affinity of the Pk moiety. A longer chain 
length allows for greater flexibility making it easier for the Pk ligand to bind to the maximum 
number of binding sites on the toxin. The Pk-derivatised gold nanoparticles of larger diameter 
were found to give a greater binding affinity. This result was thought to be due to the lower 
curvature of the nanoparticles resulting in improved interaction between the Pk ligand and 
binding sites on the toxin. Based on these results, a chip-based assay was developed 
incorporating the glyconanoparticles.81  
a)
b)
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Wang et al. found that the sensitivity of mannose-functionalised nanoparticles towards ConA 
increased with the spacer length.82 The authors prepared the glyconanoparticles using a 
photocoupling method, as previously described in this review,66 and obtained ca. 22 nm 
diameter gold nanoparticles functionalised with a mannose derivative of varying spacer lengths 
(ca. 46 Å, 27 Å, 19 Å and 13 Å). Changes of the surface plasmon absorption band of the 
glyconanoparticles were observed upon addition of the ConA. The limit of detection of each 
type of glyconanoparticle was calculated monitoring the change in the extinction at 650 nm as 
a function of the concentration of ConA. The gold nanoparticles functionalised with the longer 
and more flexible spacer linkage exhibited the lowest limit of detection.82 While these results 
appear to contradict previous work,52, 76, 78 it is possible that the flexibility of the anchor chain 
is an additional important feature for the targeting and sensitive detection of proteins with 
glyconanoparticles. 
 
 
Carbohydrate density on the nanoparticle surface 
The aggregation of glyconanoparticles, following molecular recognition, is induced by 
multivalent interactions between the analyte and the carbohydrates.83, 84 Carbohydrate 
ligand density on the nanoparticle surface is an important factor for these multivalent 
interactions19 and therefore, for colorimetric aggregation bioassays. Optimal presentation 
of the carbohydrate for efficient binding to the target may require spacer molecules 
between the ligands on the nanoparticle surface. By introducing a spacer molecule, the 
carbohydrate density on the nanoparticle can be modified for optimal target recognition 
and binding. 
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The effect of ligand density on the aggregation of gold glyconanoparticles has been studied by 
Kataoka and co-workers.70, 85 These authors synthesised gold nanoparticles stabilised with a 
mixed monolayer containing lactose-PEG-SH and acetal-PEG-SH ligands. The surface coverage 
of the glyconanoparticles with lactose was 0%, 20%, 40% and 65%. To obtain these lactose 
coverage ratios, mixtures of lactose-PEG-SH and acetal-PEG-SH ligands with the corresponding 
molar ratios were added to a solution of commercially available gold nanoparticles (ca. 20 nm 
diameter). The behaviour of the different glyconanoparticles in the presence of RCA120 lectin 
was investigated. Stable interparticle bridges were formed by the glyconanoparticles 
containing 40% and 65% lactose in the presence of RCA120 which produced the aggregation of 
the glyconanoparticles and thus a colour change. The optimal aggregation was observed for a 
65% surface coverage. Glyconanoparticles functionalised with 20% lactose did not undergo 
aggregation in the presence of RCA120, indicating the existence of a critical lactose density 
between 20% and 40% for the formation of aggregates.85 These results were confirmed by the 
work of Bergen et al. where galactose-functionalised nanoparticles were aggregated in the 
presence of RCA120.86 Commercially available gold nanoparticles were functionalised with 
different galactose ligand densities (25%, 50%, 60%, 75% and 100%). Aggregation of the 
nanoparticles was observed by measuring the extinction spectrum upon addition of RCA120. 
The optimal aggregation occurred at 75% galactose coverage and no aggregation was observed 
with a coverage of 25%.86 
 
The effect of carbohydrate density on the design of glyconanoparticles for the colorimetric 
detection of RCA120 and ConA has also been investigated.78 Gold nanoparticles were 
functionalised with a thiolated mannose derivative and a thiolated triethylene glycol in varying 
ratios. The changes in the extinction spectrum were measured following addition of increasing 
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concentrations of ConA. Glyconanoparticles with a 100% coverage of the mannose derivative 
gave the optimal aggregation in the presence of ConA. Gold nanoparticles were also 
functionalised with differing ratios of a thiolated galactose derivative (Fig. 8a) and the thiolated 
triethylene glycol to investigate the effect of carbohydrate density on RCA120 induced 
aggregation. Monitoring the changes in the extinction intensity at 620 nm, a surface coverage 
of 70% was found to be the optimal galactose density for the detection of RCA120. The limit of 
detection for RCA120 using the optimal glyconanoparticles was found to be 9 nM. The minimum 
galactose coverage required for aggregation of the galactose stabilised nanoparticles was 5 – 
7.5%.78 This study highlights that different ligand densities are required for each bioassay in 
order to obtain the optimal aggregation of the glyconanoparticles. 
 
Carbohydrate/spacer ligand ratios have been investigated to establish the optimal 
carbohydrate dilution for the rapid colorimetric detection and discrimination between human 
and avian influenza virus based on glyconanoparticles.73 Gold nanoparticles (ca. 16 nm) were 
functionalised with a trivalent α2,6-thio-linked sialic acid ligand and a thiolated polyethylene 
glycol (PEG) derivative. As described earlier, the trivalent ligand on the glyconanoparticles 
binds to the haemagglutinin on the surface of the virus inducing the aggregation of the 
nanoparticles (Fig. 6c) and, consequently, a visible colour change in solution. Marín et al. 
studied varying ratios of the trivalent α2,6-thio-linked sialic acid ligand and a thiolated 
polyethylene glycol derivative ligand. A ratio of 1:3 was found to be optimum for the 
colorimetric detection of the human influenza virus X31 (H3N2) within 30 min. The optimised 
glyconanoparticles were used to detect the virus from clinical samples of unknown 
concentration and purity. Changes in the surface plasmon absorption band of the 
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glyconanoparticles upon addition of increasing volumes of X31 influenza virus from allantoic 
fluid (AF) led to changes in the solution colour from deep red to colourless, see Fig. 9a.  
 
An important feature of the ligand reported by Marín et al. was the α2,6 configuration of the 
trivalent sialic acid (see Fig. 6a).73 While human influenza virus binds preferentially to the 
trivalent sialic acid in the α2,6 configuration, avian influenza virus binds preferentially to the 
trivalent sialic acid in a α2,3 configuration.87 Based on the sialic acid configuration preference 
of the HA of the influenza virus, the authors were able to discriminate between human and 
avian influenza virus. Increasing concentrations of the avian influenza virus RG14 (H5N1) were 
added to a sample of the trivalent sialic acid functionalised gold nanoparticles and no changes 
were observed in the extinction spectrum of the glyconanoparticles (Fig. 9b). Using the 
trivalent α2,6-thio-linked sialic acid functionalised glyconanoparticles, Marín et al. have 
developed an innovative bioassay for the detection and discrimination between human and 
avian influenza virus with results obtained within 30 min.73 
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Fig. 9. UV-visible extinction spectra of: a) trivalent ligand:PEG (1:3) functionalised gold 
nanoparticles following addition of increasing volumes of influenza AF X31 (H3N2) (from 0 to 
43.1 µL), inset: cuvettes containing trivalent ligand:PEG (1:3) functionalised gold nanoparticles 
before (left) and following (right) addition of AF X31 (43.1 µL); and b) trivalent ligand:PEG (1:3) 
functionalised gold nanoparticles following addition of increasing concentrations of avian virus 
RG14 (H5N1) (from 0 to 3.1 µg/mL).73 Figure adapted from Ref. 73. 
 
 
Conclusions  
It is apparent that the combination of carbohydrates with noble metal nanoparticles for the 
synthesis of glyconanoparticles and their application for the bioanalytical detection of lectins, 
toxins and viruses has seen significant developments over the past 12-13 years. In this tutorial 
review we have highlighted the key components that are used to construct a metal-based 
glyconanoparticle for the development colorimetric based bioassays.  
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The nanoparticle core is typically gold, although the use of silver nanoparticles has been 
reported. The predominance of gold for the core of glyconanoparticles is undoubtedly due to 
the high stability and biocompatibility of such nanoparticles. The assembly of the carbohydrate 
ligand that surrounds the silver or gold metal particle is the next consideration. Typically the 
carbohydrate ligand is self-assembled to the metal nanoparticle via a thiol moiety, although 
alternative strategies such as thioctic acid based ligands have been also reported. The 
carbohydrate used as the molecular recognition element is of central importance. The 
carbohydrate is chosen to specifically bind to the target bacterial toxin or virus for example. 
Glyconanoparticles are typically synthesised with a large number of carbohydrate molecules on 
the surface of each particle to mimic the multivalent binding observed in Nature that 
overcomes weak carbohydrate interactions. Not only do carbohydrates provide molecular 
specificity but recently it has been shown that selectivity can be achieved through differences 
of configuration of the carbohydrate ligand, with a α2,6 configured trivalent sialic acid binding 
to a human influenza virus and not an avian variant.73 The analytical sensitivity of the bioassay 
can be modified by varying the length of the chain that anchors the carbohydrate ligand to the 
gold surface. While the specificity of the glyconanoparticle bioassay can be modified by varying 
the density of the carbohydrate ligands on the metal nanoparticle.  
 
Through variation of the structure of the glyconanoparticle, the analytical performance of each 
glyconanoparticle based bioassay can be controlled. Since protein-carbohydrate and 
carbohydrate-carbohydrate interactions are ubiquitous throughout Nature, it is clear that a 
huge diversity of potential applications exist for the plasmonic-based detection of toxins, 
bacteria and viruses using glyoconanoparticles.   
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